Ant Group forged a strategic partnership with Peking University Third Hospital to establish an AI Medical Joint Innovation Laboratory. This collaboration between a top-tier hospital and a leading technology platform aims to integrate their respective strengths in clinical diagnosis and treatment, as well as in professional large models. The initiative will focus on developing and applying technologies such as medical multimodal large models and AI-facilitated clinical diagnosis and treatment across multiple departments, fostering more professional, credible, and practical AI medical applications.Related NewsHaitong Int'l: Incremental Fund Inflows Buoy Up A-shrs; Global Risk Appetite May Face Pressure Ahead of Jackson Hole SymposiumThe initial phase of the joint lab will anchor on major disease areas such as colorectal cancer, endocrinology, and assisted reproduction. The goal is to fully tackle the development of systems for AI-assisted diagnosis and decision-making, as well as patient services, aiding doctors in achieving precise treatment of complex diseases, thereby enhancing patient cure rates and post-treatment management accessibility.